INVO Fertility, Inc. - 8-K Filing
INVO Fertility reports Q3 2026 revenue growth of 26% to $2.2M alongside seventh consecutive quarter of positive Clinic-Level Adjusted EBITDA. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $IVF
Read the full article at SEC EDGAR
Part of the story INVO Fertility, Inc. - 10-Q Filing (2 articles)